Claudia Cardone
@clacardone
Followers
1K
Following
4K
Media
165
Statuses
1K
MD, PhD. GI Medical Oncologist @istitutotumori. #MCCR17. @myesmo. Neapolitan. European. #endowarrior 🎗️. Tweets are my own.
Napoli, Campania
Joined June 2017
⚡️Just OUT @ElsevierConnect
#AXL is a predictor of poor survival and of resistance to #antiEGFR therapy in patients with RAS wild-type metastatic colorectal cancer #CRCSM So proud to share this👇 https://t.co/MOEYtTcKsq
#TeamWork is the key in #CancerResearch
3
16
44
Present and future of immunotherapy? #Bridge2024 in Napoli, not to be missed @PAscierto
What we know now about upper GI according to Claudia Cardone #immunotherapy #bridge2024 @PAscierto @clacardone
0
0
8
@matteolambe is leading the most innovative research efforts to provide clear data about fertility preservation techniques and clinical outcomes in women with cancer. Sadly, this topic is still a taboo. As a woman and as oncologist, I feel so grateful. Keep shining, Matte!
Grazie mille per l’opportunità di parlare della nostra ricerca sostenuta da @AIRC_it nel campo dell’oncofertiltà rivolta alle giovani donne affette da neoplasia mammaria @UniGenova @SanMartino_Ge
1
3
14
📢 Very happy to share our latest paper Identification of Clonal Hematopoiesis Driver Mutations through In Silico Saturation Mutagenesis, just published in Cancer Discovery Explore our findings here: https://t.co/Q6KVa1UoIc 🩸🧬💻
5
14
46
“Alle bambine ribelli di tutto il mondo: sognate più in grande, puntate più in alto, lottate con più energia. E, nel dubbio, ricordate: avete ragione voi!” Quale altro meeting in sanità dà spazio a parole come queste? ♥️ @francescavallo
🗓️ 14 maggio 2024, Roma Come parlare a bambine e bambini? L'autrice di "Storie della buonanotte per bambine ribelli" - tradotto in 47 lingue in tutto il mondo - sarà con noi a #4words24. 👉 Guarda il programma, conosci i relatori e iscriviti: https://t.co/X4JXtUj7cJ
0
4
13
👉The last webinar in the #PrecisionOncology series is now available to the entire oncology community. Access with your ESMO account: 🔗 https://t.co/30JQmIj5az
@clacardone @VivekSubbiah @SewantiLimaye @BenWestphalen @GPentheroudakis
0
9
23
🚨Curious about #Tumour #agnostic treatments? Don't miss out! Join us tomorrow for an illuminating #PrecisionOncology webinar featuring international experts. 👉There's still time to register. See you there! 🌟 @myESMO @Annals_Oncology Register now with your ESMO account:
0
14
44
The #PrecisionOncology webinar presents ESMO’s new proposal for a classification of tissue-agnostic therapeutics. Register now for free and take part in this live interaction with international experts.
2
19
95
Happy Monday @AACR #AACR24! Today, I am very excited to share with you some of my unpublished PhD work @ReiseSousaLab. Come visit me at my poster in the ‘Immune cells in the tumour microenvironment 1’ session 👋 . 🗓️ Mon 8 Apr | 09:00-12:30hrs 📍 Section 9 - Board 27
1
1
7
Big thanks also to fellow #ESMOYOC members who I have had the privilege to work with over the years - you are all AWESOME! Finally, thank you 🙏 wonderful @myESMO staff, especially @franclongo & @KFumasoli - for all your support & hard work behind the scene all these years!
0
3
17
È con grande orgoglio e soddisfazione che vi comunichiamo l'approvazione al Senato della Repubblica della Legge per il #dirittoallobliooncologico. È stato premiato l’impegno di tutti quelli che hanno creduto in questa legge di civiltà che abbiamo affrontato con @AiomFondazione.
0
13
24
The first piece of knowledge from PARERE trial by @FoundationGono ✅ > 200 pts candidate to antiEGFR rechallenge screened with #liquidbiopsy 🩸 ⛔️38% RAS or BRAF mutations in ctDNA 🔢 30% RAS/BRAF wt cases with at least one potential mechanism of resistance @p_ciracimd
👏🏼Kudos to @IlBuonRossini @ChiaraCrem1 and team for their latest work, part of our research topic exploring🩸 #liquidbiopsy in #CRC 🗣️ https://t.co/1HCEqsTOlQ…
@FrontOncology @alfdestefano @DrSFacchini 👇🏼 preliminary data from the ph 2 #PARERE trial
1
17
49
👏🏼Kudos to @IlBuonRossini @ChiaraCrem1 and team for their latest work, part of our research topic exploring🩸 #liquidbiopsy in #CRC 🗣️ https://t.co/1HCEqsTOlQ…
@FrontOncology @alfdestefano @DrSFacchini 👇🏼 preliminary data from the ph 2 #PARERE trial
frontiersin.org
Retreatment with anti-EGFR monoclonal antibodies is a promising strategy in patients with RAS/BRAF wild-type (wt) metastatic colorectal cancer (mCRC) who ach...
1
4
12
👏🏼Congrats to @pashtoonkasi and team for their latest work, part of our research topic exploring🩸 liquid biopsy in CRC 🗣️ https://t.co/MVkaZFHeNI
@FrontOncology @alfdestefano @DrSFacchini 👇🏼
frontiersin.org
According to the NCI Dictionary of Cancer Terms, Liquid Biopsy is “a test done on a sample of blood to look for cancer cells from a tumor that are circulatin...
Our 1st work on Circulating Tumor Cells➖CTCs🟣🔵🟠as #LiquidBiopsies. Published @FrontOncology. Using @RareCyte ✅Feasible ⬇️Cost ➡️Tons in colorectal🆚pancreas ✔️HER2 ✔️PDL1 📉Kinetics 🙌🏾Teamwork @MlkwWalaa @AliasgerSalem
@OncoAlert @isliquidbiopsy
https://t.co/4ogX3ykDiu
2
2
15
What just happened? 5 new 💊/indications ✅ by @FDAOncology in the last 10 days. As #CommunityOncologists, we need to know them all: 1.#Fruquintinib in refractory mCRC, mPFS 3.7mos vs 1.8mos 2.#Pembrolizumab (+Chemo) in 1L mGEJ/Gastric Ca, mOS 12.9mos Vs 11.5mos
9
72
186
As a personal disclosure, I must admit that @BenWestphalen and @TeresaSAmaral have been cited as very personal example of a specific and fruitful form of #mentorship: #peermentoring Believe me, a good one.
3
1
3
During the last #SOF23 meeting, organized by @NIO_PIB we discussed a lot about #mentorship with @DrJonLim 🗣️Mentorship is a mutual relationship where toxic attitudes (from both mentor & mentee sides) -usually- perfectly match 😩We are human afterall
Food for thought…do you remember your bosses mentors in this way?
1
3
11
Patient preference for place of death is unique to their individual circumstances & belief systems 👉faith, symptom burden, social support, socioeconomic status, & geography may affect the delivery of quality #endoflife care. #OvarianCancer #gyncsm #hpm 📍 https://t.co/p3AzztEj6q
0
16
35
#AIOM23 @MassimoDiMaio75, next president elect “The person I would like to be in 10 years”, as @matteolambe said this morning👏🏼 @AIOMtweet
2
7
37